Table 3.
Perinatal outcomes of twin-to-twin transfusion syndrome cases treated with fetoscopic laser therapy during the first year of the COVID-19 pandemic (2020) and the same period of the previous year (2019)
| Outcome | 2019 (n=50) | 2020 (n=38) | P valuea |
|---|---|---|---|
| Interval between fetoscopy and delivery (wk) | 8.0 (5.2) | 8.6 (11.5) | .75 |
| PPROM | 22.0 | 31.6 | .31 |
| GA at delivery (wk) | 30.6 (5.5) | 31.4 (11.0) | .67 |
| Preterm delivery<32 wk | 44.0 | 50.0 | .58 |
| Overall survival | |||
| 1 twin | 88.0 | 76.3 | .15 |
| 2 twins | 62.0 | 52.6 | .38 |
Data are presented as mean (standard deviation) or percentage, unless otherwise indicated.
GA, gestational age; PPROM, preterm premature rupture of membranes.
a
The Student t test for independent samples or the Pearson chi-squared test was used.
López-Briones. Twin-to-twin transfusion syndrome and COVID-19. Am J Obstet Gynecol Glob Rep 2022.